alcoholism/bolesť hlavy

Odkaz sa uloží do schránky

Vyberte typ zoradenia

Strana 1 od 166 výsledky

Effects of CYP2C1917 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder*.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Background Bromodihydrochlorophenylbenzodiazepine (Phenazepam®) is used in the therapy of anxiety disorders in patients with alcohol dependence. However, Phenazepam therapy often turns out to be ineffective, and some patients develop dose-related adverse drug reactions (ADR): severe sedation,

Risk factors for headache, including TMD signs and symptoms, and their impact on quality of life. Results of the Study of Health in Pomerania (SHIP).

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

OBJECTIVE The aim of this investigation was to evaluate the role of various signs and symptoms of temporomandibular disorders (TMD), among other potential risk factors, in developing frequent headache in a population-based sample of the cross-sectional epidemiologic Study of Health in Pomerania

Predictors of treatment outcome in headache patients with the Millon Clinical Multiaxial Inventory III (MCMI-III).

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The objective was to discover possible psychological factors influencing treatment outcome for headache patients referred to psychological treatment in a tertiary headache centre by initial assessment using the Millon Clinical Multiaxial Inventory III (MCMI-III). The MCMI-III was administered to 136

Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Migraine is a highly prevalent and disabling neurological disorder associated with a wide range of psychiatric comorbidities. Studies have revealed that those with migraine headache and coexisting psychiatric disorders have poorer treatment outcomes and increased disability. The study

Neurofeedback therapy for alcohol use disorder.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Neurofeedback is a therapeutic learning process that provides visual and auditory feedback to an individual about his or her brainwaves in order to teach self-regulation of brain func- tion. Currently, neurofeedback therapy has been attempted to apply to various psychiatric disorders and certain

Association of alcohol in brain injury, headaches, and stroke with brain-tissue and serum levels of ionized magnesium: a review of recent findings and mechanisms of action.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Although there is general agreement that chronic ingestion of alcohol poses great risks for normal cardiovascular functions and peripheral-vascular homeostasis, a direct cause and effect between the real phenomena of alcohol-induced headache and risk of brain injury and stroke is not appreciated.

Lithium orotate in the treatment of alcoholism and related conditions.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The subjects were 42 alcoholic patients (33 males and 9 females) who were treated with lithium orotate during an alcohol rehabilitation program in a private clinical setting for at least six months. They derive from a total number of 105 patients who received this treatment initially, while the

Prevalence and associated factors for episodic and chronic daily headache in the Colombian population.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

There are multiple risk factors for chronic daily headache (CDH), but they are usually assessed in an isolated form without an adequate control for confounders. CDH is considered a variant of episodic headache, but studies have not gathered enough evidence to evaluate simultaneously CDH and episodic

[Post-traumatic headache].

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Head trauma (HT) and whiplash injury (WI) is followed by a posttraumatic headache (PH) in approx. 90% of patients. The PH due to common WI is located occipitally (67%), is of dull-pressing or dragging character (77%) and lasts on average 3 weeks. Tension headache is the most frequent type of PH

COVID-19: Risk of alcohol abuse and psychiatric disorders

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Alcohol abuse along with difficulties in communication has led to increased morbidity and mortality among patients with psychiatric disorders. This issue has a higher importance during the COVID-19 Pandemic. Standard recommendations to prevent the spread of infection such as self-quarantine, hand

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

UNASSIGNED Fluvoxamine therapy is used for treatment of patients with depressive disorder, but it is often ineffective, and some patients suffer from dose-dependent undesirable side effects such as vertigo, headache, indigestion, xerostomia, increased anxiety, etc. CYP2D6 is involved in the

Parental psychopathology and migraine headaches among adolescent girls.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Migraine headaches and depression often co-occur within individuals, and both syndromes run in families. However, knowledge about how these disorders relate across generations, as well as how migraine relates to other forms of psychopathology, is sparse. This study examined risk for migraine among

Naltrexone for the treatment of alcoholism.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Naltrexone is a pure opioid antagonist that is an effective nonaversive pharmacologic treatment for alcohol dependence. The usual dosage is 50 mg per day. Side effects may include nausea, headache, dizziness and arthralgia. Naltrexone appears to exert its effect by decreasing the craving for

Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Disulfiram was the first pharmacotherapy approved to treat alcohol use disorder in the 1950s. Disulfiram alters ethanol pharmacokinetics and causes uncomfortable reactions (e.g. headache, tachycardia, nausea, flushing and hypotension) when alcohol is consumed. Subsequently, a better understanding of

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Acamprosate reduces the craving for alcohol by decreasing glutamate activity and increasing gamma-aminobutyric acid (GABA) action in patients with alcohol dependence. Acamprosate has tolerable side effects that include diarrhea, headache, dizziness and pruritus. In this study, we report

Predchádzajúce
1
2
3
4
5
6
...
11
12
Ďalšie

Pripojte sa k našej
facebookovej stránke

Herbal & Natural Medicine

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Pracuje v 55 jazykoch
Bylinné lieky podporené vedou
Rozpoznávanie bylín podľa obrázka
Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
Vyhľadajte liečivé byliny podľa ich účinkov
Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

alcoholism/bolesť hlavy

Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.

Risk factors for headache, including TMD signs and symptoms, and their impact on quality of life. Results of the Study of Health in Pomerania (SHIP).

Predictors of treatment outcome in headache patients with the Millon Clinical Multiaxial Inventory III (MCMI-III).

Prevalence and comorbidity of migraine headache: results from the Singapore Mental Health Study 2016.

Neurofeedback therapy for alcohol use disorder.

Association of alcohol in brain injury, headaches, and stroke with brain-tissue and serum levels of ionized magnesium: a review of recent findings and mechanisms of action.

Lithium orotate in the treatment of alcoholism and related conditions.

Prevalence and associated factors for episodic and chronic daily headache in the Colombian population.

[Post-traumatic headache].

COVID-19: Risk of alcohol abuse and psychiatric disorders

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Parental psychopathology and migraine headaches among adolescent girls.

Naltrexone for the treatment of alcoholism.

Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Effects of CYP2C1917 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder*.